OrganoClick AB (FRA:0CF) ROCE %: 3.05% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0CF OrganoClick AB FRA:0CF
25 GF Score
Price €0.02
GF Value €0.14
! 4 Warning Signs
View Full Analysis

What is OrganoClick AB ROCE %?

OrganoClick AB FRA:0CF -10.37% 25 ROCE % is 3.05% as of Mar. 2026. GuruFocus rates FRA:0CF with a GF Score™ of 25/100 and a GF Value™ of €0.14. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. OrganoClick AB's annualized ROCE % for the quarter that ended in Mar. 2026 was 3.05%.


OrganoClick AB  (FRA:0CF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


OrganoClick AB ROCE % Related Terms


OrganoClick AB ROCE % Historical Data

* Premium members only.

The historical data trend for OrganoClick AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrganoClick AB ROCE % Chart

OrganoClick AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.51 -33.38 -11.80 -17.18 -71.54

OrganoClick AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.89 -29.76 -39.02 -126.41 3.05
FRA:0CF
25GF Score
OrganoClick AB FRA:0CF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrganoClick AB ROCE % Calculation

OrganoClick AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-2.899/( ( (11.04 - 7.007) + (12.425 - 8.354) )/ 2 )
=-2.899/( (4.033+4.071)/ 2 )
=-2.899/4.052
=-71.54 %

OrganoClick AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=0.12/( ( (12.425 - 8.354) + (13.711 - 9.921) )/ 2 )
=0.12/( ( 4.071 + 3.79 )/ 2 )
=0.12/3.9305
=3.05 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.05% mean?
OrganoClick AB (FRA:0CF) has a ROCE % of 3.05% as of Mar. 2026.
Is OrganoClick AB's ROCE % too high?
OrganoClick AB's current ROCE % is 3.05%. The Chemicals industry median ROCE % is 6.52. OrganoClick AB's value of 3.05% is 53.2% below this industry median. Overall, OrganoClick AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's ROCE % compare to LIN and SHW?
OrganoClick AB's ROCE % of 3.05% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.52. OrganoClick AB's value of 3.05% is 53.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Chemicals company?
The median ROCE % among Chemicals companies is 6.52, based on 1,589 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrganoClick AB's current ROCE % of 3.05% is 53.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrganoClick AB's current ROCE % is 3.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
OrganoClick AB (FRA:0CF) has a current ROCE % of 3.05%. The stock's GF Value™ is €0.14, compared to a current price of €0.02 — trading 82.7% below its estimated fair value. The current ROCE % is 3.05% and 53.2% below the Chemicals industry median of 6.52. OrganoClick AB's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For OrganoClick AB (FRA:0CF), the current ROCE % is 3.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrganoClick AB (FRA:0CF) Overvalued in 2026?

Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued. The current stock price of €0.02 is trading 82.7% below its estimated GF Value™ of €0.14.

Key valuation signals for FRA:0CF:

  • ROCE %: 3.05%
  • GF Value™: €0.14 vs. price of €0.02 (82.7% below fair value)
  • GF Score™: 25/100 with 4 warning signs
  • Industry Position: 53.2% below the Chemicals median

No single metric tells the full story. See the FRA:0CF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrganoClick AB Business Description

Other Exchanges ORGC:Sweden
Address Linjalvagen 9, Taby, SWE, SE-187 66
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
25GF Score

Get the complete analysis for FRA:0CF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€0.14
GF Value